Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moses Elisaf

Showing results (151-160 of 248) with videos related to

Pageof 25
Sort By:
Archives of Medical Research|December 31, 2020
Lipoprotein(a): A Concealed Precursor of Increased Cardiovascular Risk? A Real-World Regional Lipid Clinic ExperienceGeorgia Anastasiou, Eftihia Sakka, Efi Blathra, et al.
Current Medical Research and Opinion|May 23, 2002
The effects of the addition of micronised fenofibrate on uric acid metabolism in patients receiving indapamideApostolos Achimastos, Evagelos Liberopoulos, Spyros Nikas, et al.
Clinical Chemistry|October 15, 2005
Lipoprotein-associated phospholipase A2 activity is a marker of small, dense LDL particles in human plasmaIrene Gazi, Evangelia S Lourida, Theodosios Filippatos, et al.
European Journal of Internal Medicine|July 2, 2016
Proprotein convertase subtilisin kexin 9 (PCSK9) inhibitors to treat hypercholesterolemia: Effect on stroke riskHaralampos Milionis, Fotios Barkas, George Ntaios, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|June 16, 2005
Gene polymorphisms affecting HDL-cholesterol levels in the normolipidemic populationGeorge Miltiadous, Marilena Hatzivassiliou, Evagelos Liberopoulos, et al.
Journal of Cardiovascular Pharmacology|July 29, 2003
Effect of atorvastatin on the concentration, relative distribution, and chemical composition of lipoprotein subfractions in patients with dyslipidemias of type IIA and IIBVasilis Tsimihodimos, Sonia-Athena Karabina, Afroditi Tambaki, et al.
Journal of Clinical Pharmacology|October 20, 2006
Rosuvastatin increases alpha-1 microglobulin urinary excretion in patients with primary dyslipidemiaMichael S Kostapanos, Haralampos J Milionis, Irene Gazi, et al.
Global Journal of Health Science|March 2, 2016
Correlation Between the Type of Acute Coronary Syndrome With the Needs of Hospitalized PatientsMaria Polikandrioti, John Goudevenos, Lampros K Michalis, et al.
Clinical Nutrition ESPEN|January 22, 2019
Effect of combined vitamin D administration plus dietary intervention on oxidative stress markers in patients with metabolic syndrome: A pilot randomized studyStefania E Makariou, Moses Elisaf, Anna Challa, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|January 5, 2013
Effect of simvastatin/ezetimibe 10/10 mg versus simvastatin 40 mg on serum vitamin D levelsEvangelos N Liberopoulos, Stefania E Makariou, Elisavet Moutzouri, et al.
Pageof 25

Showing results (151-160 of 248) with videos related to

Sort By:
Pageof 25
Archives of Medical Research|December 31, 2020
Lipoprotein(a): A Concealed Precursor of Increased Cardiovascular Risk? A Real-World Regional Lipid Clinic ExperienceGeorgia Anastasiou, Eftihia Sakka, Efi Blathra, et al.
Current Medical Research and Opinion|May 23, 2002
The effects of the addition of micronised fenofibrate on uric acid metabolism in patients receiving indapamideApostolos Achimastos, Evagelos Liberopoulos, Spyros Nikas, et al.
Clinical Chemistry|October 15, 2005
Lipoprotein-associated phospholipase A2 activity is a marker of small, dense LDL particles in human plasmaIrene Gazi, Evangelia S Lourida, Theodosios Filippatos, et al.
European Journal of Internal Medicine|July 2, 2016
Proprotein convertase subtilisin kexin 9 (PCSK9) inhibitors to treat hypercholesterolemia: Effect on stroke riskHaralampos Milionis, Fotios Barkas, George Ntaios, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|June 16, 2005
Gene polymorphisms affecting HDL-cholesterol levels in the normolipidemic populationGeorge Miltiadous, Marilena Hatzivassiliou, Evagelos Liberopoulos, et al.
Journal of Cardiovascular Pharmacology|July 29, 2003
Effect of atorvastatin on the concentration, relative distribution, and chemical composition of lipoprotein subfractions in patients with dyslipidemias of type IIA and IIBVasilis Tsimihodimos, Sonia-Athena Karabina, Afroditi Tambaki, et al.
Journal of Clinical Pharmacology|October 20, 2006
Rosuvastatin increases alpha-1 microglobulin urinary excretion in patients with primary dyslipidemiaMichael S Kostapanos, Haralampos J Milionis, Irene Gazi, et al.
Global Journal of Health Science|March 2, 2016
Correlation Between the Type of Acute Coronary Syndrome With the Needs of Hospitalized PatientsMaria Polikandrioti, John Goudevenos, Lampros K Michalis, et al.
Clinical Nutrition ESPEN|January 22, 2019
Effect of combined vitamin D administration plus dietary intervention on oxidative stress markers in patients with metabolic syndrome: A pilot randomized studyStefania E Makariou, Moses Elisaf, Anna Challa, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|January 5, 2013
Effect of simvastatin/ezetimibe 10/10 mg versus simvastatin 40 mg on serum vitamin D levelsEvangelos N Liberopoulos, Stefania E Makariou, Elisavet Moutzouri, et al.
Pageof 25